News & Events
-
May 10, 2010
Urinary Clusterin, Cystatin C, [beta]2-Microglobulin and Total Protein as Markers to Detect Drug-Induced Kidney Injury
Dieterle F, Perentes E, Cordier A, Roth DR, Verdes P, Grenet O, Pantano S, Moulin P, Wahl D, Mahl A, End P, Staedtler F, Legay F, Carl K, Laurie D, Chibout SD, Vonderscher J, Maurer G. Urinary Clusterin, Cystatin C, [beta]2-Microglobulin and Total Protein as Markers to Detect Drug-Induced Kidney Injury. Nature Biotechnology. 2010 May;28(5):463–9.
-
May 1, 2010
Research at the Interface of Industry, Academia and Regulatory Science
Mattes WB, Walker EG, Abadie E, Sistare FD, Vonderscher J, Woodcock J, Woosley RL. Research at the Interface of Industry, Academia and Regulatory Science. Nature Biotechnology. 2010 May;28(5):432–3.
-
May 1, 2010
Evolution of Biomarker Qualification at the Health Authorities
Goodsaid F, Papaluca M. Evolution of Biomarker Qualification at the Health Authorities. Nature Biotechechnology. 2010 May;28(5):441–3.
-
May 1, 2010
Next-Generation Biomarkers for Detecting Kidney Toxicity
Bonventre JV, Vaidya VS, Schmouder R, Feig P, Dieterle F. Next-Generation Biomarkers for Detecting Kidney Toxicity. Nature Biotechnology. 2010 May;28(5):436–40.
-
May 1, 2010
A Roadmap for Biomarker Qualification
Warnock DG, Peck CC. A Roadmap for Biomarker Qualification. Nat Biotech. 2010 May;28(5):444–5.